Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Immunoadsorption versus double-dose methylprednisolone in refractory multiple sclerosis relapsesJ Neuroinflammation 2022 Sep 07;19(1)220, S Pfeuffer, L Rolfes, T Wirth, F Steffen, M Pawlitzki, A Schulte-Mecklenbeck, CC Gross, M Brand, S Bittner, T Ruck, L Klotz, H Wiendl, SG Meuth
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.